Crescent Biopharma CBIO
NASDAQ CBIO
$17.15 +0.92 (+5.67%)
At close: Aug 21, 2026 · 4:00 PM EDT

Crescent Biopharma (CBIO) Property, Plant & Equipment (Net) (2013 - 2026)

Crescent Biopharma (CBIO) Property, Plant & Equipment (Net) (2013 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Property, Plant & Equipment (Net) (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn 1.67 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn 5.46 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn 1.96 Bn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn 2.06 Bn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn 1.64 Bn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn 554.14 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn 6.80 Bn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn 107.22 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn - -
10 Crescent Biopharma 1.10 Bn 933.02 Mn - 876,000.00

Historic Data

Download Data
DateValue
Jun 30, 2026 876,000.00
Jun 30, 2026 876,000.00
Mar 31, 2026 929,000.00
Mar 31, 2026 929,000.00
Dec 31, 2025 846,000.00
Dec 31, 2025 846,000.00
Sep 30, 2025 782,000.00
Sep 30, 2025 782,000.00
Jun 30, 2025 193,000.00
Jun 30, 2025 193,000.00
Sep 30, 2023 132,979.00
Sep 30, 2023 132,979.00
Jun 30, 2023 167,859.00
Jun 30, 2023 167,859.00
Mar 31, 2023 200,747.00
Mar 31, 2023 200,747.00
Dec 31, 2022 242,390.00
Dec 31, 2022 242,390.00
Sep 30, 2022 288,107.00
Sep 30, 2022 288,107.00